Please wait while the formulary information is being retrieved.
AEMCOLO (rifamycin sodium)
- traveler's diarrhea due to noninvasive Escherichia coli
194 mg tablet,delayed release
- 2 tablets (388 mg) by oral route 2 times per day for 3 days
Default screening record
- 2 tablets (388 mg) by oral route 2 times per day
- 2 tablets (388 mg) by oral route 2 times per day for 3 days
- typhoid vaccine
- Vivotif Berna Vaccine
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Clostridioides difficile infection
Severe
Moderate
- None
AEMCOLO (rifamycin sodium)
- traveler's diarrhea due to noninvasive Escherichia coli
- None
- Constipation
- Headache disorder
More Frequent
Severe
Less Severe
- None
- Acute abdominal pain
- Dyspepsia
- Fever
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Clostridioides difficile infection
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Rifamycin
Safety and efficacy in pediatric patients less than 18 years not established.
- 1 Day – 18 Years
- Safety and efficacy in pediatric patients less than 18 years not established.
Rifamycin
- Severity Level:
2
- Additional Notes: Insuff human data; poor oral bioavailability, systemic absorption is negligible.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Rifamycin
Poor oral bioavailability; unlikely clinically significant effect on infant
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Poor oral bioavailability; unlikely clinically significant effect on infant |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Traveler's diarrhea due to noninvasive escherichia coli | |
| A04.2 | Enteroinvasive escherichia coli infection |
| A04.4 | Other intestinal escherichia coli infections |
| A09 | Infectious gastroenteritis and colitis, unspecified |
| 0-9 | A-Z |
|---|---|
| A04.2 | Enteroinvasive escherichia coli infection |
| A04.4 | Other intestinal escherichia coli infections |
| A09 | Infectious gastroenteritis and colitis, unspecified |
Formulary Reference Tool